神經介入設備的全球市場:按產品類型,最終用戶,地區 - 全球產業分析、規模、佔有率、成長、趨勢、預測（2023-2030）

預計2023年全球神經介入器材市場規模將達260億美元，並以4.7%的複合年增長率擴張，2030年底將達358億美元。

重要見解

• 神經介入器材市場規模（2023年）：260億美元
• 預測市場規模（2030F）：358億美元
• 全球市場成長率（2023-2030年複合年增長率）：4.7%
• 過去的市場成長率（2018-2022年複合年增長率）：4.3%

神經介入設備市場 - 報告範圍：

神經介入設備市場包括廣泛的醫療設備和用於診斷和治療各種神經系統疾病的微創手術的設備。這些裝置包括支架、栓塞線圈、導管、分流器等。市場的成長是由技術進步、神經系統疾病盛行率增加以及對微創外科手術的需求不斷增長等因素所推動的。此外，老年人口的增加以及隨之而來的與年齡相關的神經系統疾病的快速增加進一步推動了市場的擴張。

市場驅動因素：

全球神經介入器材市場主要受到中風、動脈瘤和腦血管畸形等神經系統疾病盛行率上升的推動。神經介入治療設備的技術進步，例如生物可吸收支架和先進成像技術的開發，顯著改善了患者的治療效果並降低了該技術的風險。此外，越來越多地採用微創神經介入技術，其特點是住院時間更短，恢復時間更短，也推動了市場的成長。

市場限制因素：

儘管成長前景廣闊，但神經介入器材市場面臨嚴格的監管要求、高技術成本和限制性報銷政策等挑戰。此外，對某些神經介入設備的長期療效和安全性的擔憂，以及與設備相關併發症相關的風險，對市場擴張構成了重大障礙。應對這些挑戰需要持續投資研發，並採取嚴格的品質控制措施，以確保產品的安全性和有效性。

市場機會：

由於持續的技術創新和對個人化醫療日益增長的興趣，神經介入設備市場提供了利潤豐厚的機會。MRI 和 CT 血管造影等影像技術的進步促進了準確的診斷和治療計劃，從而擴大了神經介入技術的範圍。此外，醫療保健基礎設施投資的增加，特別是在新興國家，正在為神經介入設備的採用創造有利的市場條件。產業參與者和醫療保健提供者共同努力開發針對特定神經系統疾病的創新治療解決方案，將進一步擴大市場成長機會。

本報告解決的關鍵問題

• 推動神經介入設備市場成長的關鍵因素是什麼？
• 哪些神經系統疾病為市場擴張提供了最大的機會？
• 科技進步如何改變神經介入設備市場的競爭格局？
• 誰是神經介入設備市場的主要參與者？他們採取什麼策略來維持其市場地位？
• 全球神經介入器材市場有哪些新趨勢和未來前景？

競爭資訊與經營策略：

全球神經介入設備市場的主要參與者：Abbott Laboratories、Becton, Dickinson and Company（BD）、Bio-Rad Laboratories, Inc.、Danaher Corporation（Cepheid）、F. Hoffmann-La Roche Ltd.（Roche Diagnostics）、Abbott Laboratories、Becton, Dickinson and Company（BD）、Bio-Rad Laboratories, Inc.（Roche Diagnostics）、Hologic, Inc.、Laboratory Corporation of America Holdings、PerkinElmer, Inc.、Quest Diagnostics、Thermo Fisher Scientific, Inc.等。專注於技術創新和策略聯盟，以提高其在市場上的影響力。這些公司正在大力投資研發，推出新的神經介入設備，以滿足未滿足的臨床需求並改善患者的治療效果。與醫療機構和學術研究中心的合作加速了尖端技術的發展並加速了臨床證據的產生。此外，對醫生培訓計劃和患者教育計劃的重視推動了市場滲透並維持競爭激烈的神經介入設備市場的長期成長。

主要公司簡介

• Abbott Laboratories
• Becton, Dickinson and Company (BD)
• Bio-Rad Laboratories, Inc.
• Danaher Corporation (Cepheid)
• F. Hoffmann-La Roche Ltd. (Roche Diagnostics)
• Hologic, Inc.
• Laboratory Corporation of America Holdings
• PerkinElmer, Inc.
• Quest Diagnostics
• Thermo Fisher Scientific, Inc.

神經介入設備市場的研究細分：

按產品

• 栓塞線圈
• 頸動脈支架
• 顱內支架
• 神經血管血栓切除術
• 栓塞保護裝置
• 分流裝置
• 囊內裝置
• 液體栓塞
• 氣球
• 支架回收器

按技術

• 神經血栓切除術
• 腦血管攝影
• 支架置入
• 捲取技術
• 血流障礙

由最終用戶

• 醫院
• 門診手術中心

按地區

• 北美
• 歐洲
• 東亞
• 南亞/大洋洲
• 拉丁美洲
• 中東/非洲

目錄

第一章內容提要

第二章市場概況

• 市場範圍和定義
• 市場動態
  • 促進因素
  • 抑制因素
  • 機會
  • 任務
  • 主要趨勢
• 產品生命週期分析
• 神經介入設備市場：價值鏈
  • 原材料供應商名單
  • 製造商名單
  • 經銷商名單
  • 應用清單
  • 獲利能力分析
• 波特五力分析
• 地緣政治緊張局勢：對市場的影響
• 宏觀經濟因素
  • 世界產業展望
  • 世界GDP成長率展望
  • 全球母公司市場概覽
• 預測變量 - 相關性和影響
• 監管和技術格局

第三章全球神經介入設備市場展望：過去（2018-2022）與預測（2023-2030）

• 主要亮點
  • 市場數量（單位）預測
  • 市場規模及年成長率
  • 絕對的財務機會
• 市場規模（百萬美元）分析與預測
  • 過去的市場規模分析，2013-2016
  • 目前市場規模預測，2018-2026
• 全球神經介入設備市場展望：產品
  • 簡介/主要發現
  • 2018-2022 年依產品歷史市場規模（百萬美元）及銷售量（單位）分析
  • 2023-2030 年按產品劃分的當前市場規模（百萬美元）和銷售量（單位）預測
  • 市場吸引力分析：產品
• 全球神經介入設備市場展望：技術
  • 簡介/主要發現
  • 2018-2022 年按技術劃分的歷史市場規模（百萬美元）和數量（單位）分析
  • 2023-2030 年按技術劃分的當前市場規模（百萬美元）和數量（單位）預測
  • 市場吸引力分析：技術
• 全球神經介入設備市場展望：最終用戶
  • 簡介/主要發現
  • 2018-2022 年歷史市場規模（百萬美元）和最終用戶數量（單位）分析
  • 2023-2030 年最終用戶目前市場規模（百萬美元）與銷售量（單位）預測
  • 市場吸引力分析：最終用戶

第四章全球神經介入設備市場展望：地區

• 主要亮點
• 2018-2022 年按地區歷史市場規模（百萬美元）及成交量（單位）分析
• 2023-2030 年各地區目前市場規模（百萬美元）及銷售量（單位）預測
  • 北美
  • 歐洲
  • 東亞
  • 南亞/大洋洲
  • 拉丁美洲
  • 中東/非洲
• 市場吸引力分析：區域

第五章北美神經介入設備市場展望：過去（2018-2022）與預測（2023-2030）

第六章歐洲神經介入設備市場展望：過去（2018-2022）與預測（2023-2030）

第七章東亞神經介入器材市場展望：過去（2018-2022）與預測（2023-2030）

第8章南亞/大洋洲神經介入設備市場展望：過去（2018-2022）與預測（2023-2030）

第9章拉丁美洲神經介入設備市場展望：過去（2018-2022）與預測（2023-2030）

第10章中東和非洲神經介入設備市場展望：過去（2018-2022）和預測（2023-2030）

第十一章競爭格局

• 2022 年市場佔有率分析
• 市場結構
• 公司簡介
  • Abbott Laboratories
  • Becton, Dickinson and Company（BD）
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation（Cepheid）
  • F. Hoffmann-La Roche Ltd.（Roche Diagnostics）
  • Hologic, Inc.
  • Laboratory Corporation of America Holdings
  • PerkinElmer, Inc.
  • Quest Diagnostics
  • Thermo Fisher Scientific, Inc.

第十二章附錄

Persistence Market Research presents a comprehensive analysis of the global neurointerventional device market, offering valuable insights into the industry's dynamics, growth drivers, challenges, and emerging trends. This report delivers an exclusive overview of the market's structure, backed by data and statistics that project the market's trajectory from 2023 to 2030.

The global neurointerventional device market is forecast to expand at a CAGR of 4.7% and thereby increase from a value of US$26 Bn in 2023, to US$ 35.8 Bn by the end of 2030.

Key Insights:

• Neurointerventional Device Market Size (2023E): US$26 Bn
• Projected Market Value (2030F): US$35.8 Bn
• Global Market Growth Rate (CAGR 2023 to 2030): 4.7%
• Historical Market Growth Rate (CAGR 2018 to 2022): 4.3%

Neurointerventional Device Market - Report Scope:

The neurointerventional device market encompasses a wide array of medical devices and equipment used in minimally invasive procedures to diagnose and treat various neurological conditions. These devices include stents, embolization coils, catheters, and flow diverters, among others. The market's growth is driven by factors such as technological advancements, increasing prevalence of neurological disorders, and growing demand for minimally invasive surgical procedures. Moreover, the rising geriatric population and the subsequent surge in age-related neurological ailments further propel market expansion.

Market Growth Drivers:

The global neurointerventional device market is primarily fueled by the escalating prevalence of neurological disorders such as stroke, aneurysms, and cerebral vascular malformations. Technological advancements in neurointerventional devices, including the development of bioresorbable stents and advanced imaging techniques, have significantly improved patient outcomes and reduced procedural risks. Additionally, the growing adoption of minimally invasive neurointerventional procedures, characterized by shorter hospital stays and quicker recovery times, augments market growth.

Market Restraints:

Despite promising growth prospects, the neurointerventional device market faces challenges such as stringent regulatory requirements, high procedural costs, and limited reimbursement policies. Moreover, concerns regarding the long-term efficacy and safety of certain neurointerventional devices, along with the risks associated with device-related complications, pose significant barriers to market expansion. Addressing these challenges requires sustained investments in research and development, along with stringent quality control measures to ensure product safety and efficacy.

Market Opportunities:

The neurointerventional device market presents lucrative opportunities driven by ongoing technological innovations and a growing focus on personalized medicine. Advancements in imaging technologies such as MRI and CT angiography facilitate precise diagnosis and treatment planning, thereby expanding the scope of neurointerventional procedures. Furthermore, increasing investments in healthcare infrastructure, particularly in emerging economies, create favorable market conditions for the adoption of neurointerventional devices. Collaborative efforts between industry players and healthcare providers to develop innovative treatment solutions tailored to specific neurological conditions further unlock growth opportunities in the market.

Key Questions Answered in the Report:

• What are the key factors driving the growth of the neurointerventional device market?
• Which neurological conditions represent the most significant opportunities for market expansion?
• How are technological advancements reshaping the competitive landscape of the neurointerventional device market?
• Who are the leading players in the neurointerventional device market, and what strategies are they employing to maintain their market positions?
• What are the emerging trends and future prospects in the global neurointerventional device market?

Competitive Intelligence and Business Strategy:

Key players in the global neurointerventional device market, including Abbott Laboratories, Becton, Dickinson and Company (BD), Bio-Rad Laboratories, Inc., Danaher Corporation (Cepheid), F. Hoffmann-La Roche Ltd. (Roche Diagnostics), Hologic, Inc., Laboratory Corporation of America Holdings, PerkinElmer, Inc., Quest Diagnostics, Thermo Fisher Scientific, Inc., focus on innovation and strategic collaborations to enhance their market presence. These companies invest heavily in research and development to introduce novel neurointerventional devices that address unmet clinical needs and offer improved patient outcomes. Collaborations with healthcare institutions and academic research centers facilitate the development of cutting-edge technologies and foster clinical evidence generation. Moreover, emphasis on physician training programs and patient education initiatives enhances market penetration and sustains long-term growth in the competitive neurointerventional device market.

Key Companies Profiled:

• Abbott Laboratories
• Becton, Dickinson and Company (BD)
• Bio-Rad Laboratories, Inc.
• Danaher Corporation (Cepheid)
• F. Hoffmann-La Roche Ltd. (Roche Diagnostics)
• Hologic, Inc.
• Laboratory Corporation of America Holdings
• PerkinElmer, Inc.
• Quest Diagnostics
• Thermo Fisher Scientific, Inc.

Neurointerventional Device Market Research Segmentation:

By Product:

• Embolic Coils
• Carotid Stents
• Intracranial Stents
• Neurovascular Thrombectomy
• Embolic Protection Device
• Flow Diverters Device
• Intrasaccular Device
• Liquid Embolic
• Balloons
• Stent Retrievers

By Technique:

• Neurothrombectomy Procedure
• Cerebral Angiography
• Stenting
• Coiling Procedures
• Flow Disruption

By End User:

• Hospitals
• Ambulatory Surgical Centers

By Region:

• North America
• Europe
• East Asia
• South Asia & Oceania
• Latin America
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Neurointerventional Device Market Snapshot, 2023 and 2030
• 1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
• 1.3. Key Market Trends
• 1.4. Future Market Projections
• 1.5. Premium Market Insights
• 1.6. Industry Developments and Key Market Events
• 1.7. PMR Analysis and Recommendations

2. Market Overview

• 2.1. Market Scope and Definition
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Opportunity
  • 2.2.4. Challenges
  • 2.2.5. Key Trends
• 2.3. Product Lifecycle Analysis
• 2.4. Neurointerventional Device Market: Value Chain
  • 2.4.1. List of Raw Material Supplier
  • 2.4.2. List of Manufacturers
  • 2.4.3. List of Distributors
  • 2.4.4. List of Applications
  • 2.4.5. Profitability Analysis
• 2.5. Porter Five Force's Analysis
• 2.6. Geopolitical Tensions: Market Impact
• 2.7. Macro-Economic Factors
  • 2.7.1. Global Sectorial Outlook
  • 2.7.2. Global GDP Growth Outlook
  • 2.7.3. Global Parent Market Overview
• 2.8. Forecast Factors - Relevance and Impact
• 2.9. Regulatory and Technology Landscape

3. Global Neurointerventional Device Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

• 3.1. Key Highlights
  • 3.1.1. Market Volume (Units) Projections
  • 3.1.2. Market Size and Y-o-Y Growth
  • 3.1.3. Absolute $ Opportunity
• 3.2. Market Size (US$ Mn) Analysis and Forecast
  • 3.2.1. Historical Market Size Analysis, 2013-2016
  • 3.2.2. Current Market Size Forecast, 2018-2026
• 3.3. Global Neurointerventional Device Market Outlook: Product
  • 3.3.1. Introduction / Key Findings
  • 3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product, 2018 - 2022
  • 3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
    • 3.3.3.1. Embolic Coils
    • 3.3.3.2. Carotid Stents
    • 3.3.3.3. Intracranial Stents
    • 3.3.3.4. Neurovascular Thrombectomy
    • 3.3.3.5. Embolic Protection Device
    • 3.3.3.6. Flow Diverters Device
    • 3.3.3.7. Intrasaccular Device
    • 3.3.3.8. Liquid Embolic
    • 3.3.3.9. Balloons
    • 3.3.3.10. Stent Retrievers
• 3.4. Market Attractiveness Analysis: Product
• 3.5. Global Neurointerventional Device Market Outlook: Technique
  • 3.5.1. Introduction / Key Findings
  • 3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Technique, 2018 - 2022
  • 3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technique, 2023 - 2030
    • 3.5.3.1. Neurothrombectomy Procedure
    • 3.5.3.2. Cerebral Angiography
    • 3.5.3.3. Stenting
    • 3.5.3.4. Coiling Procedures
    • 3.5.3.5. Flow Disruption
• 3.6. Market Attractiveness Analysis: Technique
• 3.7. Global Neurointerventional Device Market Outlook: End User
  • 3.7.1. Introduction / Key Findings
  • 3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2018 - 2022
  • 3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 3.7.3.1. Hospitals
    • 3.7.3.2. Ambulatory Surgical Centers
• 3.8. Market Attractiveness Analysis: End User

4. Global Neurointerventional Device Market Outlook: Region

• 4.1. Key Highlights
• 4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
• 4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
  • 4.3.1. North America
  • 4.3.2. Europe
  • 4.3.3. East Asia
  • 4.3.4. South Asia and Oceania
  • 4.3.5. Latin America
  • 4.3.6. Middle East & Africa (MEA)
• 4.4. Market Attractiveness Analysis: Region

5. North America Neurointerventional Device Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

• 5.1. Key Highlights
• 5.2. Pricing Analysis
• 5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
  • 5.3.1. By Country
  • 5.3.2. By Product
  • 5.3.3. By Technique
  • 5.3.4. By End User
• 5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
  • 5.4.1. U.S.
  • 5.4.2. Canada
• 5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
  • 5.5.1. Embolic Coils
  • 5.5.2. Carotid Stents
  • 5.5.3. Intracranial Stents
  • 5.5.4. Neurovascular Thrombectomy
  • 5.5.5. Embolic Protection Device
  • 5.5.6. Flow Diverters Device
  • 5.5.7. Intrasaccular Device
  • 5.5.8. Liquid Embolic
  • 5.5.9. Balloons
  • 5.5.10. Stent Retrievers s
• 5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technique, 2023 - 2030
  • 5.6.1. Neurothrombectomy Procedure
  • 5.6.2. Cerebral Angiography
  • 5.6.3. Stenting
  • 5.6.4. Coiling Procedures
  • 5.6.5. Flow Disruption
• 5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
  • 5.7.1. Hospitals
  • 5.7.2. Ambulatory Surgical Centers
• 5.8. Market Attractiveness Analysis

6. Europe Neurointerventional Device Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

• 6.1. Key Highlights
• 6.2. Pricing Analysis
• 6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
  • 6.3.1. By Country
  • 6.3.2. By Product
  • 6.3.3. By Technique
  • 6.3.4. By End User
• 6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
  • 6.4.1. Germany
  • 6.4.2. France
  • 6.4.3. U.K.
  • 6.4.4. Italy
  • 6.4.5. Spain
  • 6.4.6. Russia
  • 6.4.7. Turkiye
  • 6.4.8. Rest of Europe
• 6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
  • 6.5.1. Embolic Coils
  • 6.5.2. Carotid Stents
  • 6.5.3. Intracranial Stents
  • 6.5.4. Neurovascular Thrombectomy
  • 6.5.5. Embolic Protection Device
  • 6.5.6. Flow Diverters Device
  • 6.5.7. Intrasaccular Device
  • 6.5.8. Liquid Embolic
  • 6.5.9. Balloons
  • 6.5.10. Stent Retrievers
• 6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technique, 2023 - 2030
  • 6.6.1. Neurothrombectomy Procedure
  • 6.6.2. Cerebral Angiography
  • 6.6.3. Stenting
  • 6.6.4. Coiling Procedures
  • 6.6.5. Flow Disruption
• 6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
  • 6.7.1. Hospitals
  • 6.7.2. Ambulatory Surgical Centers
• 6.8. Market Attractiveness Analysis

7. East Asia Neurointerventional Device Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

• 7.1. Key Highlights
• 7.2. Pricing Analysis
• 7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
  • 7.3.1. By Country
  • 7.3.2. By Product
  • 7.3.3. By Technique
  • 7.3.4. By End User
• 7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
  • 7.4.1. China
  • 7.4.2. Japan
  • 7.4.3. South Korea
• 7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
  • 7.5.1. Embolic Coils
  • 7.5.2. Carotid Stents
  • 7.5.3. Intracranial Stents
  • 7.5.4. Neurovascular Thrombectomy
  • 7.5.5. Embolic Protection Device
  • 7.5.6. Flow Diverters Device
  • 7.5.7. Intrasaccular Device
  • 7.5.8. Liquid Embolic
  • 7.5.9. Balloons
  • 7.5.10. Stent Retrievers
• 7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technique, 2023 - 2030
  • 7.6.1. Neurothrombectomy Procedure
  • 7.6.2. Cerebral Angiography
  • 7.6.3. Stenting
  • 7.6.4. Coiling Procedures
  • 7.6.5. Flow Disruption
• 7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
  • 7.7.1. Hospitals
  • 7.7.2. Ambulatory Surgical Centers
• 7.8. Market Attractiveness Analysis

8. South Asia & Oceania Neurointerventional Device Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

• 8.1. Key Highlights
• 8.2. Pricing Analysis
• 8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
  • 8.3.1. By Country
  • 8.3.2. By Product
  • 8.3.3. By Technique
  • 8.3.4. By End User
• 8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
  • 8.4.1. India
  • 8.4.2. Southeast Asia
  • 8.4.3. ANZ
  • 8.4.4. Rest of South Asia & Oceania
• 8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
  • 8.5.1. Embolic Coils
  • 8.5.2. Carotid Stents
  • 8.5.3. Intracranial Stents
  • 8.5.4. Neurovascular Thrombectomy
  • 8.5.5. Embolic Protection Device
  • 8.5.6. Flow Diverters Device
  • 8.5.7. Intrasaccular Device
  • 8.5.8. Liquid Embolic
  • 8.5.9. Balloons
  • 8.5.10. Stent Retrievers
• 8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technique, 2023 - 2030
  • 8.6.1. Neurothrombectomy Procedure
  • 8.6.2. Cerebral Angiography
  • 8.6.3. Stenting
  • 8.6.4. Coiling Procedures
  • 8.6.5. Flow Disruption
• 8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
  • 8.7.1. Hospitals
  • 8.7.2. Ambulatory Surgical Centers
• 8.8. Market Attractiveness Analysis

9. Latin America Neurointerventional Device Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

• 9.1. Key Highlights
• 9.2. Pricing Analysis
• 9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
  • 9.3.1. By Country
  • 9.3.2. By Product
  • 9.3.3. By Technique
  • 9.3.4. By End User
• 9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
  • 9.4.1. Brazil
  • 9.4.2. Mexico
  • 9.4.3. Rest of Latin America
• 9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
  • 9.5.1. Embolic Coils
  • 9.5.2. Carotid Stents
  • 9.5.3. Intracranial Stents
  • 9.5.4. Neurovascular Thrombectomy
  • 9.5.5. Embolic Protection Device
  • 9.5.6. Flow Diverters Device
  • 9.5.7. Intrasaccular Device
  • 9.5.8. Liquid Embolic
  • 9.5.9. Balloons
  • 9.5.10. Stent Retrievers
• 9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technique, 2023 - 2030
  • 9.6.1. Neurothrombectomy Procedure
  • 9.6.2. Cerebral Angiography
  • 9.6.3. Stenting
  • 9.6.4. Coiling Procedures
  • 9.6.5. Flow Disruption
• 9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
  • 9.7.1. Hospitals
  • 9.7.2. Ambulatory Surgical Centers
• 9.8. Market Attractiveness Analysis

10. Middle East & Africa Neurointerventional Device Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

• 10.1. Key Highlights
• 10.2. Pricing Analysis
• 10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
  • 10.3.1. By Country
  • 10.3.2. By Product
  • 10.3.3. By Technique
  • 10.3.4. By End User
• 10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
  • 10.4.1. GCC
  • 10.4.2. Egypt
  • 10.4.3. South Africa
  • 10.4.4. Northern Africa
  • 10.4.5. Rest of Middle East & Africa
• 10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
  • 10.5.1. Embolic Coils
  • 10.5.2. Carotid Stents
  • 10.5.3. Intracranial Stents
  • 10.5.4. Neurovascular Thrombectomy
  • 10.5.5. Embolic Protection Device
  • 10.5.6. Flow Diverters Device
  • 10.5.7. Intrasaccular Device
  • 10.5.8. Liquid Embolic
  • 10.5.9. Balloons
  • 10.5.10. Stent Retrievers
• 10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Technique, 2023 - 2030
  • 10.6.1. Neurothrombectomy Procedure
  • 10.6.2. Cerebral Angiography
  • 10.6.3. Stenting
  • 10.6.4. Coiling Procedures
  • 10.6.5. Flow Disruption
• 10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
  • 10.7.1. Hospitals
  • 10.7.2. Ambulatory Surgical Centers
• 10.8. Market Attractiveness Analysis

11. Competition Landscape

• 11.1. Market Share Analysis, 2022
• 11.2. Market Structure
  • 11.2.1. Competition Intensity Mapping By Market
  • 11.2.2. Competition Analog IC
  • 11.2.3. Apparent Product Capacity
• 11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 11.3.1. Abbott Laboratories
    • 11.3.1.1. Overview
    • 11.3.1.2. Segments and Product
    • 11.3.1.3. Key Financials
    • 11.3.1.4. Market Developments
    • 11.3.1.5. Market Strategy
  • 11.3.2. Becton, Dickinson and Company (BD)
    • 11.3.2.1. Overview
    • 11.3.2.2. Segments and Product
    • 11.3.2.3. Key Financials
    • 11.3.2.4. Market Developments
    • 11.3.2.5. Market Strategy
  • 11.3.3. Bio-Rad Laboratories, Inc.
    • 11.3.3.1. Overview
    • 11.3.3.2. Segments and Product
    • 11.3.3.3. Key Financials
    • 11.3.3.4. Market Developments
    • 11.3.3.5. Market Strategy
  • 11.3.4. Danaher Corporation (Cepheid)
    • 11.3.4.1. Overview
    • 11.3.4.2. Segments and Product
    • 11.3.4.3. Key Financials
    • 11.3.4.4. Market Developments
    • 11.3.4.5. Market Strategy
  • 11.3.5. F. Hoffmann-La Roche Ltd. (Roche Diagnostics)
    • 11.3.5.1. Overview
    • 11.3.5.2. Segments and Product
    • 11.3.5.3. Key Financials
    • 11.3.5.4. Market Developments
    • 11.3.5.5. Market Strategy
  • 11.3.6. Hologic, Inc.
    • 11.3.6.1. Overview
    • 11.3.6.2. Segments and Product
    • 11.3.6.3. Key Financials
    • 11.3.6.4. Market Developments
    • 11.3.6.5. Market Strategy
  • 11.3.7. Laboratory Corporation of America Holdings
    • 11.3.7.1. Overview
    • 11.3.7.2. Segments and Product
    • 11.3.7.3. Key Financials
    • 11.3.7.4. Market Developments
    • 11.3.7.5. Market Strategy
  • 11.3.8. PerkinElmer, Inc.
    • 11.3.8.1. Overview
    • 11.3.8.2. Segments and Product
    • 11.3.8.3. Key Financials
    • 11.3.8.4. Market Developments
    • 11.3.8.5. Market Strategy
  • 11.3.9. Quest Diagnostics
    • 11.3.9.1. Overview
    • 11.3.9.2. Segments and Product
    • 11.3.9.3. Key Financials
    • 11.3.9.4. Market Developments
    • 11.3.9.5. Market Strategy
  • 11.3.10. Thermo Fisher Scientific, Inc.
    • 11.3.10.1. Overview
    • 11.3.10.2. Segments and Product
    • 11.3.10.3. Key Financials
    • 11.3.10.4. Market Developments
    • 11.3.10.5. Market Strategy

12. Appendix

• 12.1. Research Methodology
• 12.2. Research Assumptions
• 12.3. Acronyms and Abbreviations